# Marinus Pharmaceuticals (stock symbol: MRNS) Logo in transparent PNG and SVG formats

## Marinus Pharmaceuticals Logo large

### Marinus Pharmaceuticals Logo large Download PNG (39.53 KB)

![Marinus Pharmaceuticals Logo large Download PNG (39.53 KB)](/img/orig/MRNS_BIG-7b6bdfd1.png)

### Marinus Pharmaceuticals Logo large Download SVG (2.8 KB)

![Marinus Pharmaceuticals Logo large Download SVG (2.8 KB)](/img/orig/MRNS_BIG-86416883.svg)

## Marinus Pharmaceuticals Logo icon format

### Marinus Pharmaceuticals Logo icon format Download PNG (91.43 KB)

![Marinus Pharmaceuticals Logo icon format Download PNG (91.43 KB)](/img/orig/MRNS-a0264111.png)

### Marinus Pharmaceuticals Logo icon format Download SVG (2 KB)

![Marinus Pharmaceuticals Logo icon format Download SVG (2 KB)](/img/orig/MRNS-1a8d1797.svg)

## Marinus Pharmaceuticals Logo large for dark backgrounds

### Marinus Pharmaceuticals Logo large for dark backgrounds Download PNG (25.07 KB)

![Marinus Pharmaceuticals Logo large for dark backgrounds Download PNG (25.07 KB)](/img/orig/MRNS_BIG.D-544562b7.png)

### Marinus Pharmaceuticals Logo large for dark backgrounds Download SVG (2.75 KB)

![Marinus Pharmaceuticals Logo large for dark backgrounds Download SVG (2.75 KB)](/img/orig/MRNS_BIG.D-87d2a246.svg)

## Marinus Pharmaceuticals Logo icon format for dark backgrounds

### Marinus Pharmaceuticals Logo icon format for dark backgrounds Download PNG (51.39 KB)

![Marinus Pharmaceuticals Logo icon format for dark backgrounds Download PNG (51.39 KB)](/img/orig/MRNS.D-5231c933.png)

### Marinus Pharmaceuticals Logo icon format for dark backgrounds Download SVG (1.95 KB)

![Marinus Pharmaceuticals Logo icon format for dark backgrounds Download SVG (1.95 KB)](/img/orig/MRNS.D-860454c3.svg)

## About Marinus Pharmaceuticals

Marinus Pharmaceuticals, Inc., a pharmaceutical company, focuses on development and commercialization of products for patients suffering from rare genetic epilepsies and other seizure disorders. It offers ZTALMY, an oral suspension for the treatment of seizures associated with cyclin-dependent kinase-like 5 deficiency disorder for adult and pediatric patient populations in acute and chronic care, and in-patient and self-administered settings. The company's ZTALMY product candidate acts at synaptic and extrasynaptic GABAA receptors, a target for its anti-seizure, antidepressant, and anxiolytic potential. It is developing ganaxolone for treating genetic epilepsy disorders, such as PCDH19-related epilepsy, tuberous sclerosis complex, depressive disorders, and Lennox-Gestaut Syndrome. Marinus Pharmaceuticals, Inc. has license agreement with Purdue Neuroscience Company and CyDex Pharmaceuticals, Inc.; and collaboration agreement with Orion Corporation. The company was incorporated in 2003 and is headquartered in Radnor, Pennsylvania.

1. Website domain: marinuspharma.com
2. Employees: 113
3. Marketcap: $0.45 Billion USD


## Categories
- [x] ðŸ‡ºðŸ‡¸ United States
- [x] ðŸ’Š Pharmaceuticals
- [x] ðŸ§¬ Biotech
